GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Initiator Pharma AS (OSTO:INIT) » Definitions » Current Deferred Revenue

Initiator Pharma AS (OSTO:INIT) Current Deferred Revenue : kr0.00 Mil (As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Initiator Pharma AS Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Initiator Pharma AS's current deferred revenue for the quarter that ended in Dec. 2024 was kr0.00 Mil.

Initiator Pharma AS Current Deferred Revenue Historical Data

The historical data trend for Initiator Pharma AS's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Initiator Pharma AS Current Deferred Revenue Chart

Initiator Pharma AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only - - - - -

Initiator Pharma AS Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Initiator Pharma AS Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Initiator Pharma AS's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Initiator Pharma AS Business Description

Traded in Other Exchanges
N/A
Address
Co/ COBIS, Ole Maaloesvej 3, Copenhagen, DNK, 2200
Initiator Pharma AS is a research and development company engaged in the pharmaceutical development of drugs to be used for erectile dysfunction, depression, and pain. It Research is focused in the area of monoamine reuptake inhibitors.

Initiator Pharma AS Headlines

No Headlines